β-Carbolines as specific inhibitors of cyclin-Dependent kinases

β-Carbolines as specific inhibitors of cyclin-Dependent kinases Aryl[ a ]pyrrolo[3,4- c ]carbazoles as selective cyclin D1-CDK4 inhibitors Structure–activity relationship study of beta-carboline derivatives as haspin kinase inhibitors Novel Trisubstituted Harmine Derivatives with Original in Vitro Anticancer Activity Pyrrolo[2,3-a]carbazoles as Potential Cyclin Dependent Kinase 1 (CDK1) Inhibitors. Synthesis, Biological Evaluation, and Binding Mode through Docking Simulations Antitumor agents 201.1 Cytotoxicity of harmine and β-carboline analogs Design, synthesis and biological evaluation of β-carboline derivatives as novel inhibitors targeting B-Raf kinase Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinases Nitrogen-containing flavonoid analogues as CDK1/cyclin B inhibitors: Synthesis, SAR analysis, and biological activity Cyclin-Dependent Kinase Inhibition by New C-2 Alkynylated Purine Derivatives and Molecular Structure of a CDK2−Inhibitor Complex